The EpiDerm™ Skin Irritation Test (EpiDerm™ SIT)

  • Helena KandarovaEmail author
  • Manfred Liebsch


Assessment of the skin irritation belongs to the basic battery of toxicology tests. Due to the enormous efforts from test methods developers, validation centers and regulators, several in vitro test methods have been developed, validated and regulatory adopted as potential replacements of the rabbit skin irritation test.

This chapter describes in details the skin irritation test (SIT) based on the use of the in vitro reconstructed human epidermis model EpiDerm™ (EpiDerm™ SIT). The EpiDerm™ SIT is a validated and regulatory adopted method under the OECD Test Guidelines 439 along with three other tissue models. The chapter focuses on the technical details of this assay and also provides information about the performance of this test method obtained during the validation study. Part of this chapter also describes other EpiDerm™ skin irritation protocols that can be used for the safety assessment of final cosmetic products and for testing extracts from Medical Devices in line with the ISO 10993.


  1. 1.
    United Nations (UN). Globally harmonized system of classification and labeling of chemicals (GHS), 2nd revised edn, UN New York and Geneva, 2007. Available:
  2. 2.
    OECD. OECD guideline for testing of chemicals, No. 404: acute dermal irritation/corrosion. Organisation for economic cooperation and development, Paris; 2015.Google Scholar
  3. 3.
    Draize JH, Woodand G, Calvery HO. Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes. J Pharmacol Exp Ther. 1944;82:337–90.Google Scholar
  4. 4.
    Portes P, Grandidier M-H, Cohen C, Roguet R. Refinement of the Episkin protocol for the assessment of acute skin irritation of chemicals: follow-up to the ECVAM prevalidation study. Toxicol In Vitro. 2002;16:765–70.CrossRefPubMedGoogle Scholar
  5. 5.
    Cotovio J, Grandidier M-H, Portes P, Roguet R, Rubinstenn G. The In Vitro acute skin irritation of chemicals: optimisation of the EPISKIN prediction model within the framework of the ECVAM validation process. ATLA. 2005;33:329–49.PubMedGoogle Scholar
  6. 6.
    Kandárová H, Liebsch M, Genschow E, Gerner I, Traue D, Slawik B, Spielmann H. Optimization of the EpiDerm™ test protocol for the upcoming ECVAM validation study on in vitro skin irritation tests. ALTEX. 2004;21(3/04):107–14.PubMedGoogle Scholar
  7. 7.
    Kandárová H, Liebsch M, Gerner I, Schmidt E, Genschow E, Traue D, Spielmann H. EpiDerm™ skin irritation test protocol–assessment of the performance of the optimized test. ATLA. 2005;33(4):351–67.PubMedGoogle Scholar
  8. 8.
    Spielmann H, Hoffmann S, Liebsch M, Botham P, Fentem J, Eskes C, Roguet R, Cotovio J, Cole T, Worth A, Heylings J, Jones P, Robles C, Kandárová H, Gamer A, Remmele M, Curren R, Raabe H, Cockshott A, Gerner I, Zuang V. The ECVAM international validation study on in vitro tests for acute skin irritation: report on the validity of the EPISKIN and EpiDerm™ assays and on the skin integrity function test. ATLA. 2007;35:559–601.PubMedGoogle Scholar
  9. 9.
    ESAC. Statement on the scientific validity of in-vitro tests for skin irritation testing, April 2007. 2007. Downloadable from
  10. 10.
    Kandárová H, Liebsch M, Gerner I, Schmidt E, Genschow E, Traue D, Spielmann H. The EpiDerm test protocol for the upcoming ECVAM validation study on skin irritation tests—an assessment of the performance of the optimized test. ATLA. 2005;33:351–67.PubMedGoogle Scholar
  11. 11.
    Liebsch M, Gamer A, Curren R, Frank J, Genschow E, Tharmann J, Remmele M, Bauer B, Raabe H, Barnes N, Hilberer A, Wilt N, Lorngjad-Schäfer MR, Schäfer C, Spiller E, Hayden P, Kanďárová H. Follow-up validation of the modified EpiDerm™ skin irritation test (SIT): results of a multicentre study of twenty reference test substances. 15th congress on alternatives to animal experimentation, September 19-21 Linz, Austria. ALTEX. 2008;25(Suppl 1):43.Google Scholar
  12. 12.
    Liebsch M, Kandarova H. Submission of the follow-up validation study of the modified EpiDerm™ skin irritation test for hazard identification and labelling of chemicals according to EU classification system. 23 April 2008; 2008. p. 58, 10 Annexes.Google Scholar
  13. 13.
    OECD. Guidance document no. 34 on the validation and international acceptance of new or updated test methods for hazard assessment. Paris: OECD; 2005.Google Scholar
  14. 14.
    ECVAM. Performance standards for applying human skin models to in vitro skin irritation; 2007. Available under download study document, at
  15. 15.
    ESAC. Statement on the scientific validity of in-vitro tests for skin irritation testing, November 2008; 2008. Downloadable from
  16. 16.
    EU. B.46 Guideline. In Vitro skin irritation: reconstructed human epidermis (RHE) model test; 2009.Google Scholar
  17. 17.
    Mossman T. Rapid colorimetric assay for cell growth and survival application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65:55–63.CrossRefGoogle Scholar
  18. 18.
    Faller C, Bracher N, Dami N, Roguet R. Predictive ability of reconstructed human epidermis equivalents for assessment of skin irritation of cosmetics. Toxicol In Vitro. 2002;16(5):557–72.CrossRefPubMedGoogle Scholar
  19. 19.
    Faller C, Bracher M. Reconstructed skin kits: reproducibility of cutaneous irritating testing. Skin Pharmacol Appl Ski Physiol. 2002;15(Suppl 1):74–91.CrossRefGoogle Scholar
  20. 20.
    OECD. Test no. 439: in vitro skin irritation reconstructed human epidermis test method. Organisation for economic cooperation and development, 23 July 2010. 2010.Google Scholar
  21. 21.
    ESAC. Esac statement on the performance standards (ps) for in vitro 2 skin irritation testing using reconstructed human epidermis; 2009. Downloadable from:
  22. 22.
    Kandárová H, Hayden P, Klausner M, Kubilus J, Sheasgreen J. An In Vitro skin irritation test (SIT) using the EpiDerm™ reconstructed human epidermal (RHE) model. JoVE. 2009;29 doi: 10.3791/1366.
  23. 23.
    MatTek SOP In Vitro EpiDerm™ Skin Irritation Test (EPI-200-SIT) For use with MatTek Corporation’s Reconstructed Human Epidermal Model EpiDerm™ (EPI-200-SIT). Doc. MK-24-007-0023, Version 07/11/2014; 2014. p. 35.Google Scholar
  24. 24.
    Jírová D, Basketter D, Liebsch M, Bendová H, Kejlová K, Marriott M, Kandárová H. Comparison of human skin irritation patch test data with in vitro skin irritation assays and animal data. Contact Dermatitis. 2010;62(2):109–16. doi: 10.1111/j.1600-0536. 2009.01640.x.CrossRefPubMedGoogle Scholar
  25. 25.
    Cannon CL, Neal PJ, Southee JA, Kubilus J, Klausner M. New epidermal model for dermal irritancy testing. Toxicol In Vitro. 1994;8:889–91.CrossRefPubMedGoogle Scholar
  26. 26.
    OECD GD No. 203. Guidance document on an integrated approach on testing and assessment (IATA) for skin corrosion and irritation. Series on testing and assessment; 2014.
  27. 27.
    Casas JW, Lewerenz GM, Rankin EA, Willoughby JA Sr, Blakeman LC, McKim JM Jr, Coleman KP. In vitro human skin irritation test for evaluation of medical device extracts. Toxicol In Vitro. 2013;27(2013):2175–83.CrossRefPubMedGoogle Scholar
  28. 28.
    Kandarova H, Willoughby JA, de Jong WH, Bachelor MA, Letasiova S, Milasova T, Breyfogle B, de la Fonteyne L, Coleman KP. Development, optimization, and standardization of an in vitro skin irritation test for medical devices using the reconstructed human tissue model EpiDerm. SOT 2015. The Toxicologist, 2015. p. 433. Scholar

Copyright information

© Springer International Publishing AG 2017

Authors and Affiliations

  1. 1.MatTek In vitro Life Science LaboratoriesBratislavaSlovakia
  2. 2.Retired Head of Unit “Centre of Alternative Methods to Animal Experiments–ZEBET” at the BfRBerlinGermany

Personalised recommendations